John W. Dougherty, III , D.O., David Neubauer, M.D.
Narcolepsy is a topic covered in the Johns Hopkins Psychiatry Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --


  • Narcolepsy is characterized by impaired sleep and wakefulness, along with rapid eye movement (REM) sleep abnormalities.
  • The clinical tetrad includes the following, although only 10% of those affected will have all 4 symptoms:
    • Excessive daytime sleepiness
    • Hallucinations occurring at the transition from wakefulness to sleep (hypnagogic)
    • Sleep paralysis
    • Cataplexy
  • Disrupted nighttime sleep is common, but the most disabling symptoms are daytime inattention and hypersomnolence.
    • Especially during sedentary activities
    • Sometimes with irrepressible sleep attacks
  • Cataplexy is a brief (usually less than 2 minutes) symmetrical sudden loss of muscle tone with preserved consciousness, typically precipitated by strong emotions (especially laughter).
    • Episodes may range from very subtle (e.g., neck or jaw weakness) to complete collapse.
  • Type 1 narcolepsy requires the presence of cataplexy or decreased CSF hypocretin (orexin) levels.
  • Type 2 narcolepsy involves abnormalities evident upon nighttime and daytime sleep laboratory testing.
  • Narcolepsy is classified under the Sleep-Wake Disorders section of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)[1].

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: October 17, 2014